Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases

Journal of Clinical Pathology

Volumn 66, Issue 3, 2013, Pages 205-211

  Wang, Lai Mun ^a,b   Jani, Anant R ^a,b   Hill, Esme J ^b   Sharma, Ricky A ^a,b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CETUXIMAB; FLUORODEOXYGLUCOSE; FLUOROURACIL; IRINOTECAN; OXALIPLATIN; YTTRIUM 90;

ARTICLE; CALCIFICATION; CANCER RADIOTHERAPY; CASE REPORT; CHEST INFECTION; COLORECTAL CANCER; CORONARY ARTERY SPASM; DRUG UPTAKE; DRUG WITHDRAWAL; FEMALE; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER METASTASIS; LIVER PARENCHYMA; LIVER SURGERY; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RADIATION INJURY; SELECTIVE INTERNAL RADIATION THERAPY; TUMOR NECROSIS; VASCULAR TUMOR;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MICROSPHERES; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84874653883     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201231     Document Type: Article

References (23)

1. Cabibbo G, Latteri F, Antonucci M, et al. Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol 2009;6:159-69.
2. Kerr D, McArdle C, Ledermann J, et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 2003;361:368-73.
3. Nicolay NH, Berry DP, Sharma RA. Liver metastases from colorectal cancer: radioembolization with systemic therapy. Nature Rev Clin Oncol 2009;6: 687-97.
4. Boerhaave H. Academical lectures on the theory of physic being. A genuine translation of his institutes and explanatory comment. London: W. Innys, 1774.
5. Willis RA. Mitosis in the hepatic metastases of malignant tumours. J Path & Bact 1932;35:11.
6. Wright RD. The blood supply of newly developed epithelial tissue in the liver. J Path & Bact 1937;45:405-14.
7. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-77.
8. Sullivan R, Miller E, Sikes M. Antimetabolite-metabolite combination cancer chemotherapy. Cancer 1959;12:1248-62.
9. Brennan M, Talley E, Drake E, et al. 5-fluorouracil treatment of liver metastases by continuous hepatic artery infusion via Cournand catheter. Ann Surgery 1963;158:405-19.
10. Doyon D, Mouzon A, Jourde A, et al. Hepatic, arterial embolization in patients with malignant liver tumours (author's transl from French). Ann Radiol (Paris) 1974;17:593-603.
11. Nakakuma K, Tashiro S, Hiraoka T, et al. Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 1983;52:2193-200.
12. Sharma RA, Wasan HS, Love SB, et al. on behalf of the FOXFIRE trial management group. FOXFIRE: a Phase III Clinical Trial of Chemo-radio- embolisation as first-line treatment of liver metastases in patients with colorectal cancer. Clin Oncol 2008;20:261-3.
13. Sharma RA, Van Hazel G, Morgan B, et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007;25:1099-106.
14. Van den Eynde M, Flamen P, Nakadi IE, et al. Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioemblization with yttrium-90 microspheres. Clin Nuc Med 2008;33:697-8.
15. Whitney R, Tatum C, Hahl M, et al. Safety of hepatic resection in metastastic disease to the liver after yttrium-90 therapy. J Surg Res 2011;166:236-40.
16. Fajardo LF, Berthrong M, Anderson RE. Radiation pathology. New York: Oxford University Press USA, 2001: 153-63.
17. Rubbia-Brandt L, Audard V, Sartoretti P. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460-6.
18. Guan S, Zhao W, Zhou K, et al. Assessment of hemodynamics in precancerous lesion of hepatocellular carcinoma: Evaluation with MR perfusion. World J Gastroenterol 2007;13:1182-6.
19. Dezso K, Bugyik E, Papp V, et al. Development of arterial blood supply in experimental liver metastases. Am J Pathol 2009;175:835-43.
20. Kudo M, Tochio H. Intranodular blood supply correlates well with biological malignancy grade determined by tumor growth rate in pathologically proven hepatocellular carcinoma. Oncology 2008;75(Suppl 1):55-64.
21. Tsushima Y, Funabasama S, Aoki J, et al. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 2004;11:215-23.
22. Hadaki M, Praseedom R, Brais R, et al. Selective internal radiation therapy with 90Y-SIR-Spheres microspheres for non-resectable colorectal metastases in the liver. BMJ Case report 2011. pii: bcr0120113793. doi: 10.1136/bcr.01.2011.3793.
23. Kennedy A, Nag S, Salem R, et al. Recommendations for radioembolization of hepatic malignancies using Yttrium-90 (Y90) microsphere brachytherapy: a consensus panel report from the Radioembolization Brachytherapy Oncology Consortium (REBOC). Int J Rad Oncol Biol Phys 2007;68:13-23.